MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
6.10
-0.39
-6.01%
After Hours: 6.13 +0.03 +0.49% 19:48 08/14 EDT
OPEN
6.32
PREV CLOSE
6.49
HIGH
6.40
LOW
6.08
VOLUME
7.96M
TURNOVER
--
52 WEEK HIGH
7.32
52 WEEK LOW
1.700
MARKET CAP
2.18B
P/E (TTM)
-5.5485
1D
5D
1M
3M
1Y
5Y
1D
Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice
NASDAQ · 2d ago
AppLovin Stock Leads 3 Fast Growing Insider Backed Picks To Watch
Simply Wall St · 6d ago
Weekly Report: what happened at PGEN last week (0803-0807)?
Weekly Report · 6d ago
3 Fast Growing US Stocks Investors Are Screening For Insider Backing
Simply Wall St · 6d ago
Precigen (PGEN) Could Be 50% Undervalued On Strong Earnings Turnaround
Simply Wall St · 08/09 13:26
Precigen: Has To Grow Into Its Valuation
Seeking Alpha · 08/08 06:07
Precigen (PGEN) Is Up 16.3% After Papsimios-Fueled Return To Profitability And Broad Payer Coverage
Simply Wall St · 08/07 03:31
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement
Seeking Alpha · 08/06 19:39
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.